REC-3964 is Recursion’s first new chemical entity developed using the RecursionOS. REC-3964 represents a novel, non-antibiotic approach with a unique mechanism of action that binds and blocks ...
Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from ...
Recursion Pharma is an AI-driven drug developer that boasts supercomputers designed to shorten drug development timelines and enhance successful outcomes. Many such companies have raised substantial ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback